| Oncogenic point mutations in the Myb DNA-binding domain alter the DNA-binding properties of Myb at a physiological target gene. | None |
| Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk. | None |
| Proposed structure for the DNA-binding domain of the Myb oncoprotein based on model building and mutational analysis. | None |
| C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences. | None |
| c-Myb is an evolutionally conserved target of miR-150 and miR-150/c-Myb interaction is important for embryonic development and possibly oncogenesis | None |
| c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. | None |
| The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. | None |
| v-myb transformation of Xeroderma pigmentosum human fibroblasts: overexpression of the c-Ha-ras oncogene in the transformed cells. | None |
| Intermolecular recombination of human c-myb proto-oncogene coding sequences. | None |
| The MYB-NFIB fusion is a hallmark of adenoid cystic carcinomas (ACC) and deregulation of the expression of MYB and its target genes is a key oncogenic event in the pathogenesis of ACC.[MYB-NFIB fusion prtoein] | None |
| Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-myb. | None |
| Presence of circulating anti-c-myb oncogene product antibodies in human sera. | None |
| Hep27 is regulated at the transcriptional level by the proto-oncogene c-Myb and is required for c-Myb-induced p53 stabilization. | None |
| Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53. | None |
| Ribosomal protein L4 positively regulates activity of a c-myb proto-oncogene product. | None |
| Data show that the proto-oncogene c-Myb controls Slug transcription in tumor cells of different origin. Such a regulatory pathway contributes to the acquisition of invasive properties that are important for the metastatic process. | None |
| Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. | None |
| New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer. | None |
| Protein truncation is required for the activation of the c-myb proto-oncogene. | None |
| Intermolecular recombination of the c-myb proto-oncogene coding sequences in chicken: clues for a mechanism. | None |